Actively Recruiting

Phase Not Applicable
All Genders
ID06660433

imProving Respiratory Outbreak Mitigation Through Point-of-care Testing in Long Term Care (PROMPT-LTC): A Cluster Randomized Trial

Led by Michael Garron Hospital · Updated on 2025-12-02

24

Participants Needed

2

Research Sites

43 weeks

Total Duration

On this page

Sponsors

M

Michael Garron Hospital

Lead Sponsor

S

Sunnybrook Health Sciences Centre

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating whether faster testing for respiratory viruses like Influenza, COVID-19, and Respiratory Syncytial Virus (RSV) can reduce the number and size of virus outbreaks in long-term care homes. The trial compares rapid point-of-care testing with existing laboratory testing methods to see if quicker results help control virus spread among residents. This study is led by Michael Garron Hospital and involves long-term care facilities linked to specific Ontario Health Teams. The study involves two groups: one uses a point-of-care respiratory test platform located within the care facility to provide quick test results, while the other group continues using the existing respiratory virus testing platforms. The rapid testing device aims to deliver results faster than traditional lab methods, potentially allowing for timely infection control measures. The study is randomized and does not include blinding. Participants are long-term care residents in facilities engaged with Ontario Health Teams overseen by Sunnybrook Health Science Centre, Michael Garron Hospital, or Humber River Health. Researchers will track the number of residents infected with the targeted viruses over seven months, along with outbreak frequency, hospital transfers, deaths, outbreak duration, and secondary attack rates. No study blinding is used, and the trial runs until March 2026, monitoring outcomes at various intervals from 14 days to 60 days depending on the measure.

CONDITIONS

Brief Title

Respiratory Outbreak Mitigation in Long-Term Care Using Point-of-Care Testing

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Long-term care facility engaged with an Ontario Health Team overseen by Sunnybrook Health Science Centre, Michael Garron Hospital or Humber River Health
Not Eligible

You will not qualify if you...

  • No signed statement of agreement for study participation
  • Pre-existing use of a point-of-care testing platform

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 7 months

Participants receive a point-of-care respiratory test platform or an existing respiratory virus testing platform as part of the trial to provide rapid test results within long-term care facilities.

Ongoing testing and monitoring during the trial period

Surveillance

Duration - 7 months

Participants are monitored for respiratory virus infections and outbreaks within the long-term care facilities.

Regular observation without additional visits

Trial Site Locations

Total: 2 locations

1

Michael Garron Hospital

Toronto, Ontario, Canada, M4C 3E7

Actively Recruiting

2

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada, M4N 3M5

Actively Recruiting

Loading map...

Research Team

C

Christopher Kandel, MD, PhD

J

Jerome Leis, MD, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Similar Trials

Development and Effectiveness of a New Intervention on House...

Attitude to Health

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial